423 results on '"De Angelis, Antonella"'
Search Results
2. Chapter Monitoraggio, conservazione e informazione nella Baia Di Ieranto: un modello circolare per la gestione delle Aree Marine Protette
3. Effects of sacubitril-valsartan on aging-related cardiac dysfunction
4. Space inside the wall, space outside the wall. The contribution of the macro-lithic and chipped stone tools use-wear analysis to disclose the role of the monumental wall in the EBA village of Arslantepe (Malatya, Turkey)
5. Correction: c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration
6. Myocardial regeneration protocols towards the routine clinical scenario: An unseemly path from bench to bedside
7. Colchicine in ischemic heart disease: the good, the bad and the ugly
8. Adrenoceptor Blockers : Influence on Depression and Anxiety
9. Complementing daily fire-danger assessment using a novel metric based on burnt area ranking
10. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects.
11. Branched-chain amino acids and L-alanine supplementation ameliorate calcium dyshomeostasis in sarcopenia: New insights for nutritional interventions.
12. FUS driven circCNOT6L biogenesis in mouse and human spermatozoa supports zygote development
13. Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch
14. In vitro CSC-derived cardiomyocytes exhibit the typical microRNA-mRNA blueprint of endogenous cardiomyocytes
15. Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?
16. Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch.
17. Adult Multipotent Cardiac Progenitor-Derived Spheroids: A Reproducible Model of In Vitro Cardiomyocyte Commitment and Specification
18. Adrenoceptor Blockers
19. Monitoraggio, conservazione e informazione nella Baia Di Ieranto: un modello circolare per la gestione delle Aree Marine Protette
20. Chapter 3.12 - Neutral endopeptidase (neprilysin)
21. COVID-19 and atrial fibrillation: Intercepting lines
22. Myocardial Regeneration by Activation of Multipotent Cardiac Stem Cells in Ischemic Heart Failure
23. COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database
24. A Mouse Model of Dilated Cardiomyopathy Produced by Isoproterenol Acute Exposure Followed by 5-Fluorouracil Administration
25. Human cardiac progenitor cells with regenerative potential can be isolated and characterized from 3D-electro-anatomic guided endomyocardial biopsies
26. Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity
27. Adrenoceptor Blockers
28. Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome
29. COVID-19 and atrial fibrillation: Intercepting lines
30. Streptozotocin-Induced Type 1 and 2 Diabetes Mellitus Mouse Models Show Different Functional, Cellular and Molecular Patterns of Diabetic Cardiomyopathy
31. Cytochalasin D restores nuclear size acting on F-actin and IZUMO1 localization in low-quality spermatozoa
32. Long-term administration of ranolazine attenuates diastolic dysfunction and adverse myocardial remodeling in a model of heart failure with preserved ejection fraction
33. SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy
34. Pharmacological clearance of senescent cells improves cardiac remodeling and function after myocardial infarction in female aged mice
35. c-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration
36. SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells
37. Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?
38. Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
39. Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials
40. Ranolazine Counteracts Strength Impairment and Oxidative Stress in Aged Sarcopenic Mice
41. Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors
42. Doxorubicin targets multiple players: A new view of an old problem
43. Monographic issue of pharmacological research on adult myocardial repair/regeneration
44. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction
45. Effects of ranolazine in a model of doxorubicin‐induced left ventricle diastolic dysfunction
46. Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
47. The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
48. Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age
49. Unraveling and Targeting Myocardial Regeneration Deficit in Diabetes
50. Renoprotection by Dapagliflozin in a Non-Diabetic Model of Cardiorenal Syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.